Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?
NCT ID: NCT03277417
Last Updated: 2017-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2017-09-30
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postnatal Managemant of Prenetal Cardiac Echogenic Foci in Hillel Yaffe Medical Center
NCT04265352
Speckle Tracking Echocardiography in Infants, Prenatally and Postnatally
NCT05601375
Single Ventricle Outcome
NCT00308217
The Relationship Between Fetal Baseline Heart-rate and the Level of Acetyl-choline Esterase in Fetal Blood
NCT03478267
Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects
NCT00860327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Isolated Oligohydramnios
Fetuses with amniotic fluid index (AFI) equal or less than 5 cm
Echocardiography
Imaging of fetal heart and amniotic fluid
Isolated Polyhydramnios
Fetuses with amniotic fluid index (AFI) more than 25 cm
Echocardiography
Imaging of fetal heart and amniotic fluid
Control Group
Fetuses with normal amount of amniotic fluid
Echocardiography
Imaging of fetal heart and amniotic fluid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiography
Imaging of fetal heart and amniotic fluid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancies
Exclusion Criteria
* Known fetal cardiac defect
* Suspected fetal infection
* Suspected IUGR
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rinat Gabbay-Benziv, MD
Role: PRINCIPAL_INVESTIGATOR
Hillel Yaffe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillel Yaffe Medical Center
Hadera, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC-0037-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.